Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

STAAR Surgical to Report First Quarter Results on May 5, 2021
STAAR Surgical to Report First Quarter Results on May 5, 2021


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release

EOS imaging Reports its Full Year 2020 Results and First Quarter 2021 Revenues
EOS imaging Reports its Full Year 2020 Results and First Quarter 2021 Revenues


Regulatory News:



EOS imaging (Euronext, FR0011191766 - EOSI - Eligible PEA - PME) (Paris:EOSI), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year
Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year


Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and

LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine
LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for B-Capta®, the new

Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time
Lantheus Holdings to Host First Quarter 2021 Earnings Conference Call and Webcast on May 4, 2021 at 8:00 a.m. Eastern Time


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Tuesday, May 4, 2021, to discuss its financial and

U.S. FDA Renews Licenses of DILIsym Software
U.S. FDA Renews Licenses of DILIsym Software


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS)

Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test


Illumina, Inc. (NASDAQ: ILMN), today announced that it disagrees with the European Commission’s Directorate-General for Competition’s decision to review Illumina’s acquisition of GRAIL, a company

Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test


Illumina, Inc. (NASDAQ: ILMN), today announced that it disagrees with the European Commission’s Directorate-General for Competition’s decision to review Illumina’s acquisition of GRAIL, a company

Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test


Illumina, Inc. (NASDAQ: ILMN), today announced that it disagrees with the European Commission’s Directorate-General for Competition’s decision to review Illumina’s acquisition of GRAIL, a company

LivaNova Achieves Clinical Milestone in Heart Failure Program
LivaNova Achieves Clinical Milestone in Heart Failure Program


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has randomized the 300th patient in the Autonomic Regulation Therapy to Enhance Myocardial

Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology
Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology


Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing

Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin


Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals. This new

Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin


Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals. This new

Eckert & Ziegler baut in Berlin GMP-Anlage für radiopharmazeutische Dienstleistungen
Eckert & Ziegler baut in Berlin GMP-Anlage für radiopharmazeutische Dienstleistungen


Eckert & Ziegler erweitert seinen Produktionsstandort in Berlin um eine neue Produktionsanlage für die Auftragsfertigung von Radiopharmazeutika. Die neue GMP-Anlage mit einer Gesamtfläche von rund

Eckert & Ziegler baut in Berlin GMP-Anlage für radiopharmazeutische Dienstleistungen
Eckert & Ziegler baut in Berlin GMP-Anlage für radiopharmazeutische Dienstleistungen


Eckert & Ziegler erweitert seinen Produktionsstandort in Berlin um eine neue Produktionsanlage für die Auftragsfertigung von Radiopharmazeutika. Die neue GMP-Anlage mit einer Gesamtfläche von rund

Agilent Named One of Singapore’s Best Employers
Agilent Named One of Singapore’s Best Employers


Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a

Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization
Waters and Genovis Collaborate to Develop Efficient Workflows for Biopharmaceutical Characterization


Waters Corporation (NYSE:WAT) and Genovis AB (Nasdaq First North Growth Market) are formally collaborating to develop and market complete routine biopharmaceutical characterization workflows based

Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results
Simulations Plus Reports Record Second Quarter Fiscal 2021 Financial Results


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today reported

Community Healthcare System Partners with Premier, Inc. to Drive Operational Innovation and High-Quality Patient Care
Community Healthcare System Partners with Premier, Inc. to Drive Operational Innovation and High-Quality Patient Care


Community Healthcare System, recognized for high-quality care across Northwest Indiana, has partnered with Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company. Through this new

NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference
NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of spatial biology abstracts that

Lantheus Expands R&D Leadership Team with Key New Hires
Lantheus Expands R&D Leadership Team with Key New Hires


Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions

Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company
Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has received initial

Dexcom Starts Direct Distribution in the Netherlands
Dexcom Starts Direct Distribution in the Netherlands


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today it has ended its distribution collaboration with Zkope

Dexcom Starts Direct Distribution in the Netherlands
Dexcom Starts Direct Distribution in the Netherlands


DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today it has ended its distribution collaboration with Zkope

Premier, Inc. to Report Fiscal 2021 Third-Quarter Results and Host Conference Call on May 4, 2021
Premier, Inc. to Report Fiscal 2021 Third-Quarter Results and Host Conference Call on May 4, 2021


Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 third quarter on Tuesday, May 4, 2021, at approximately 6:30 a.m. ET. The company will also